MYRIAD GENETICS, INC. Total Liabilities
MYRIAD GENETICS, INC. (MYGN) had Total Liabilities of $335.00 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-07-31
- 2026-06-30: Liabilities $335.00M.
- 2026-03-31: Liabilities $336.30M.
- 2025-12-31: Liabilities $338.60M.
- 2025-09-30: Liabilities $355.30M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $335.00M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $336.30M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $338.60M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $355.30M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $289.20M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $301.20M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $326.50M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $349.60M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $344.60M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $350.50M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $363.30M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $465.70M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $452.00M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $334.10M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $312.90M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $295.40M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $262.80M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $305.30M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $352.90M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $367.40M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $457.90M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $461.70M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $537.80M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $535.20M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $486.40M 10-KT · filed 2021-03-16 | |
| 2020-03-31 | $479.50M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $501.00M 10-Q · filed 2020-02-07 | |
| 2019-09-30 | $516.70M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $473.80M 10-KT · filed 2021-03-16 | |
| 2019-03-31 | $475.60M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $492.50M 10-Q · filed 2019-02-06 | |
| 2018-09-30 | $471.40M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $209.20M 10-K · filed 2019-08-13 | |
| 2018-03-31 | $270.10M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $314.30M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $357.70M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $440.90M 10-K · filed 2018-08-24 | $446.60M 10-K · filed 2017-08-09 |
| 2017-03-31 | $519.90M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $543.40M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $535.60M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $132.40M 10-K · filed 2017-08-09 | |
| 2016-03-31 | $98.00M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $100.90M 10-Q · filed 2016-02-03 | |
| 2015-09-30 | $99.90M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $104.10M 10-K · filed 2016-08-10 | |
| 2015-03-31 | $110.15M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $87.61M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $96.86M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $104.80M 10-K · filed 2015-08-12 | $104.82M 10-K · filed 2014-08-13 |
| 2014-03-31 | $94.18M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $80.71M 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $91.39M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $75.23M 10-K · filed 2014-08-13 | |
| 2013-03-31 | $64.10M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $55.63M 10-Q · filed 2013-02-06 | |
| 2012-09-30 | $67.49M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $54.98M 10-K · filed 2013-08-14 | |
| 2012-03-31 | $47.06M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $44.49M 10-Q · filed 2012-02-01 | |
| 2011-09-30 | $40.74M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $44.03M 10-K · filed 2012-08-15 | |
| 2011-03-31 | $32.82M 10-Q · filed 2011-05-04 | |
| 2010-12-31 | $32.51M 10-Q · filed 2011-02-01 | |
| 2010-09-30 | $39.73M 10-Q · filed 2010-11-03 | |
| 2010-06-30 | $36.27M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |